Dendritic cell differentiation blocked by primary effusion lymphoma-released factors is partially restored by inhibition of P38 MAPK.
To better understand the molecular mechanisms underlying the dendritic cell (DC) defects in cancer, we analyzed which signaling pathway is implicated in the abnormal monocyte differentiation into DC determined by the presence of Primary effusion lymphoma (PEL) released factors. Our results indicate that the DC, obtained in this condition, together with phenotypic abnormalities and reduced allostimulatory function, showed hyperphosphorylation of signal transducer and activator of transcription 3 (STAT3) and p38 mitogen-activated protein kinase (MAPK) molecules, in comparison to the DC differentiated in the absence of PEL-released factors. The inhibition of p38 MAPK but not of STAT3 phosphorylation, with specific inhibitors, was able to revert the effect of the PEL-released factors on the DC phenotype. This study suggests that p38 MAPK signaling pathway is an important contributor to the abnormal differentiation of DC in PEL.
Istituto Pasteur-Fondazione Cenci Bolognetti, Department of Experimental Medicine University of Rome Sapienza, Rome, Italy. mara.cirone@uniromal.it
M
M
Cirone
L
L
Di Renzo
P
P
Trivedi
G
G
Lucania
G
G
Borgia
L
L
Frati
A
A
Faggioni
D002454:Cell Differentiation; D002460:Cell Line; D003713:Dendritic Cells / Q000473:pathology*; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors; D054685:Lymphoma, Primary Effusion / Q000473:pathology*; D020935:MAP Kinase Signaling System; D016328:NF-kappa B / Q000502:physiology; D010766:Phosphorylation; D050796:STAT3 Transcription Factor / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism
D016328:NF-kappa B; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D048051:p38 Mitogen-Activated Protein Kinases